SCHEMBL31129093

SCHEMBL31129093

CC(C)[C@H](N)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C

nearest known ligand 0.38

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ SLC7A5 Q01650 1/20 0.37
▸ CTSD P07339 2/20 0.37
▸ DPP4 P27487 1/20 0.37
▸ FAP Q12884 1/20 0.37
▸ DPP8 Q6V1X1 1/20 0.37
▸ DPP9 Q86TI2 1/20 0.37
▸ DPP7 Q9UHL4 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.36
▸ SDCBP O00560 2/20 0.36
▸ SDC2 P34741 2/20 0.36
▸ MME P08473 1/20 0.36
▸ EPHX2 P34913 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29551119 0.97 DPP4 (0.38) NPSR1SMN1; SMN2SLC7A5CTSDDPP4
SCHEMBL30668291 0.95 DPP4 (0.39) NPSR1SMN1; SMN2SLC7A5CTSDDPP4
SCHEMBL30052907 0.95 NPSR1 (0.41) NPSR1SMN1; SMN2SLC7A5DPP4FAP
SCHEMBL29448573 0.92 DPP4 (0.41) NPSR1SMN1; SMN2SLC7A5DPP4FAP
SCHEMBL34464920 0.90 OPRD1 (0.38) SLC7A5CTSDDPP4FAPDPP8
SCHEMBL31588230 0.86 ALDH1A1 (0.43) SLC7A5DPP4FAPDPP8DPP9
SCHEMBL29421862 0.86 NPSR1 (0.39) NPSR1SMN1; SMN2ALDH1A1SDCBPSDC2
SCHEMBL29349612 0.84 ALDH1A1 (0.42) NPSR1SMN1; SMN2ALDH1A1SDCBPSDC2
SCHEMBL27941881 0.84 ALDH1A1 (0.41) DPP4FAPDPP8DPP9DPP7
SCHEMBL7344585 0.84 DPP4 (0.50) NPSR1SMN1; SMN2SLC7A5CTSDDPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4602074-A1 NOVEL CD19-TARGETING POLYPEPTIDES AND CD19-DIRECTED IMMUNOTHERAPIES The Trustees of The University of Pennsylvania (US) 2025-08-20 — — EP disclosed
WO-2024227055-A1 NOVEL CD19-TARGETING POLYPEPTIDES AND CD19-DIRECTED IMMUNOTHERAPIES THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2024-10-31 — — WO disclosed
WO-2023108138-A9 FULLY CANINE ANTI-CANINE PD-1 ANTIBODIES AND USES THEREOF THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2024-09-26 — — WO disclosed
Send feedback